Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00125996Phase 2Unknown
Phase 2, randomised, single-blind trial in chronic heart failure (CHF) and iron deficiency anemia (IDA) comparing IV iron sucrose with Placebo (2 arms). Primary endpoint: Peak Oxygen Consumption at 18 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00125996.